Oxford's Brazil vaccine trial to continue after volunteer dies - university

The spread of the coronavirus disease (COVID-19) in Oxford

LONDON (Reuters) - The University of Oxford's Brazilian trial of its vaccine candidate will continue after the death of a volunteer, the university said on Wednesday, adding an independent review had revealed no safety concerns.

"Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial and the independent review in addition to the Brazilian regulator have recommended that the trial should continue," a spokesman for the university said in a statement.

The vaccine has been licenced to AstraZeneca.

(Reporting by Alistair Smout; Editing by Chris Reese)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting